None of these above studies have deeply studied the regulatory mechanism of cisatracurium in cancer cells, but it is noteworthy that in colorectal cancer (CRC), Yabasin et al reported that cisatracurium could upregulate the expression of p53 protein and then inhibit the metastasis of CRC cells [11]. This evidence concerns the gene TP53 and colorectal cancer.